share_log

エアトリ---続伸、バイオアクセルへの出資を発表

Air Tree has announced its investment in BioAxcel and the stock continues to rise.

Fisco Japan ·  Jul 18 01:32


AirTree <6191> continues to rise. The company has announced investment in BioAxl, which supports the cultivation and processing of immunocytes for medical institutions for the treatment of malignant tumors. This capital participation is part of the investment business and is expected to return based on BioAxl's future growth. It seems to be considering a future listing, and expects to provide support for efficient preparation by leveraging the company's listing experience and know-how.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment